Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al
Kokkorakis M, Chakhtoura M, Rhayem C, et al
clinical work used GHK-Cu in the ~0.1% topical range
When volatile, destructive molecules known as reactive oxygen species (ROS) or "free radicals"such as hydroxyl radicals (HO) and peroxynitritethreaten to damage cellular DNA, lipids, or proteins, glutathione steps in
Metabolic syndrome and urinary cGMP excretion in general population
For comparison, GHK-Cu differs from NAD+ therapy, which targets cellular energy pathways rather than tissue remodeling